Volume | 388 503 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 7,70 | Bas Haut |
|||||
Minimum Bas | 6,86 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Larimar Therapeutics Inc | LRMR | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
6,86 | 6,86 | 7,70 | 7,35 | 6,89 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
5 851 | 388 503 | US$ 7,36 | US$ 2 860 955 | - | 2,18 - 13,68 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
22:20:05 | formt | 120 | US$ 7,35 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
63,16M | 63,80M | - | 0 | -36,95M | -0,58 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Larimar Therapeutics
Date | Heure | Source | Titre |
---|---|---|---|
11/3/2024 | 21:09 | Edgar (US Regulatory) | Form 8-K - Current report |
16/2/2024 | 22:06 | Edgar (US Regulatory) | Form 8-K - Current report |
15/2/2024 | 02:57 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
14/2/2024 | 23:08 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
14/2/2024 | 14:55 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
14/2/2024 | 12:06 | Edgar (US Regulatory) | Form 8-K - Current report |
13/2/2024 | 22:46 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
12/2/2024 | 13:03 | Edgar (US Regulatory) | Form 8-K - Current report |
19/1/2024 | 22:33 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
19/1/2024 | 22:32 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
19/1/2024 | 22:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
19/1/2024 | 22:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
Forum Action Larimar Therapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Larimar Therapeutics Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 6,48 | 7,70 | 5,91 | 6,56 | 244 589 | 0,87 | 13,43% |
1 mois | 7,89 | 8,056 | 5,91 | 6,96 | 338 738 | -0,54 | -6,84% |
3 mois | 6,20 | 13,68 | 5,70 | 9,69 | 678 550 | 1,15 | 18,55% |
6 mois | 2,90 | 13,68 | 2,18 | 8,65 | 395 681 | 4,45 | 153,45% |
1 an | 4,96 | 13,68 | 2,18 | 6,75 | 318 289 | 2,39 | 48,19% |
3 ans | 13,32 | 15,49 | 1,53 | 6,18 | 209 814 | -5,97 | -44,82% |
5 ans | 12,00 | 25,87 | 1,53 | 6,92 | 171 249 | -4,65 | -38,75% |